v3.26.1
Cover - USD ($)
 12 Months Ended
Dec. 31, 2025
Mar. 29, 2026
Jun. 30, 2025
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2025    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2025    
Current Fiscal Year End Date --12-31    
Entity File Number 001-42204    
Entity Registrant Name EXOZYMES INC.    
Entity Central Index Key 0002010788    
Entity Tax Identification Number 83-4550057    
Entity Incorporation, State or Country Code NV    
Entity Address, Address Line One 750 Royal Oaks Drive    
Entity Address, Address Line Two Suite 106    
Entity Address, City or Town Monrovia    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 91016    
City Area Code (626)    
Local Phone Number 415-1488    
Title of 12(b) Security Common Stock, $.000001    
Trading Symbol EXOZ    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers Yes    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Elected Not To Use the Extended Transition Period true    
Entity Shell Company false    
Entity Public Float     $ 38,418,884
Entity Common Stock, Shares Outstanding   8,478,992  
Documents Incorporated By Reference None    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Entity Listing, Par Value Per Share $ 7.23    
Auditor Opinion [Text Block] We have audited the accompanying consolidated balance sheets of eXoZymes, Inc. (FKA Invizyne Technologies, Inc.) and its subsidiaries (the “Company”) as of December 31, 2025 and 2024, and the related consolidated statements of operations, changes in stockholders’ equity and cash flows for each of the years in the two-year period ended December 31, 2025 and the related notes (collectively referred to as the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2025 and 2024, and the results of its operations and its cash flows for each of the years in the two-year period ended December 31, 2025, in conformity with accounting principles generally accepted in the United States of America    
Auditor Name RBSM LLP    
Auditor Firm ID 587    
Auditor Location Las Vegas, Nevada